BCL2L1 and lymphoma: This indicates that apoptosis inhibition due to overexpression of the anti-apoptotic proteins is also a reason for the resistance to TRAIL ligand, but the Bcl-xL protein is at least not the main cause of the observed resistance in canine lymphoma cells.